Where does Agile Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Agile Therapeutics, Inc. ranks #22,147 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Agile Therapeutics, Inc. hold?

Agile Therapeutics, Inc. holds 12 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Agile Therapeutics, Inc.'s Innovation Score?

Agile Therapeutics, Inc. has an Innovation Score of 29.1 out of 100 (30th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Agile Therapeutics, Inc. focus on?

Agile Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 12 patents, ranking #1,877 of 7,163 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Agile Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Agile Therapeutics, Inc.'s recent grant velocity is -90% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Agile Therapeutics, Inc.'s patents?

Agile Therapeutics, Inc.'s patents average 10.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Agile Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Agile Therapeutics, Inc.

USPTO PatentsView assignee record - 12 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Agile ranks #22,147 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 4 technology areas.

#22,147
of 49,997 US assignees by volume: 30th percentile
by Innovation Score (29.1/100): 10.9
avg claims per patent: -90%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22147 · US Corporation #22,147 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,147/49,997
PHOTO-FINISH Advinus Therapeutics
CPC-NARROW A61K · 4 areas
INNOV-THIN 29.1/100
CLAIMS-PAR 10.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -90% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Advinus Therapeutics Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Agile’s 29.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (30%) Velocity 6.7 pts (23%) Breadth 7.1 pts (24%) Claim depth 6.6 pts (23%)

Qualcomm Incorporated · highest

85
Aeroprobe · near

29
Agile Therapeutics · this assignee

29
Anchorfree · near

29
Hanall Biopharma · near

29
LTT Bio-Pharma · near

29
3D Lighting… · lowest

7

What this shows Agile's Innovation Score is 29.1/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Agile?

Each dot is one of Agile’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Agile’s own 10.9 claims/patent is at or below the 15.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Agile vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Agile's grants concentrate

Agile Therapeutics, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2016. By volume, Agile sits between Advinus Therapeutics Limited and Allberry B.V..

Agile's three-year grant acceleration

Agile Therapeutics, Inc. shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Advinus Therapeut…

12
Aemea

12
Aerogel

12
Afferent Pharmace…

12
Aktivax

12
Alastin Skincare

12
Alertenterprise

12
Allberry B V

12
Agile Therapeutics ◀

12

What this shows Agile holds 12 patents at rank #22,196, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Agile

By rank, the assignees closest to #22,196 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Agile's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Agile, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Agile ranks #1,877 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Hanall Biopharma Co., Ltd. 29 Aeroprobe Corporation 29 Anchorfree Inc. 29 LTT Bio-Pharma Co., Ltd. 29

Agile's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Agile Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	41.7%
2016	1	8.3%
2017	4	33.3%
2024	1	8.3%
2025partial year	1	8.3%

Which technologies does Agile Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Agile Therapeutics, Inc.'s patent record in context - here's where to go next.

Agile Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #22,147 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Agile Therapeutics, Inc. against Advinus Therapeutics Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.